|
Gene therapy
Citations 31-40 of 80 total displayed.
|
Past content
(since Jan 1999):
|
- Brief Reviews
Therapeutic Potential of Endothelial Progenitor Cells in Cardiovascular Diseases
- Victor J. Dzau, Massimiliano Gnecchi, Alok S. Pachori, Fulvio Morello, and Luis G. Melo
Hypertension 2005;46:7-18; published online before print as doi:10.1161/01.HYP.0000168923.92885.f7
[Abstract]
[Full text]
- Scientific Contributions
Therapeutic Potential of Endothelial Progenitor Cells in Cardiovascular Diseases
- Victor J. Dzau, Massimiliano Gnecchi, Alok S. Pachori, Fulvio Morello, and Luis G. Melo
Hypertension published June 13, 2005, doi:10.1161/01.HYP.0000168923.92885.f7
[Abstract]
- Scientific Contributions
Selective Silencing of Angiotensin Receptor Subtype 1a (AT1aR) by RNA Interference
- Jorge Vázquez, María F. Correa de Adjounian, Colin Sumners, Aaron González, Carlos Diez-Freire, and Mohan K. Raizada
Hypertension 2005;45:115-119; published online before print as doi:10.1161/01.HYP.0000150161.78556.c6
[Abstract]
[Full text]
- Scientific Contributions
Selective Silencing of Angiotensin Receptor Subtype 1a (AT1aR) by RNA Interference
- Jorge Vázquez, María F. Correa de Adjounian, Colin Sumners, Aaron González, Carlos Diez-Freire, and Mohan K. Raizada
Hypertension published November 29, 2004, doi:10.1161/01.HYP.0000150161.78556.c6
[Abstract]
- Scientific Contributions
Essential Role of Vascular Endothelial Growth Factor in Angiotensin IIInduced Vascular Inflammation and Remodeling
- Qingwei Zhao, Minako Ishibashi, Ken-ichi Hiasa, Chunyan Tan, Akira Takeshita, and Kensuke Egashira
Hypertension 2004;44:264-270; published online before print as doi:10.1161/01.HYP.0000138688.78906.6b
[Abstract]
[Full text]
- Scientific Contributions
Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease
- Ryuichi Morishita, Motokuni Aoki, Naotaka Hashiya, Hirofumi Makino, Keita Yamasaki, Junya Azuma, Yoshiki Sawa, Hikaru Matsuda, Yasufumi Kaneda, and Toshio Ogihara
Hypertension 2004;44:203-209; published online before print as doi:10.1161/01.HYP.0000136394.08900.ed
[Abstract]
[Full text]
- Scientific Contributions
Essential Role of Vascular Endothelial Growth Factor in Angiotensin II-Induced Vascular Inflammation and Remodeling
- Qingwei Zhao, Minako Ishibashi, Ken-ichi Hiasa, Chunyan Tan, Akira Takeshita, and Kensuke Egashira
Hypertension published July 19, 2004, doi:10.1161/01.HYP.0000138688.78906.6b
[Abstract]
- Scientific Contributions
Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease
- Ryuichi Morishita, Motokuni Aoki, Naotaka Hashiya, Hirofumi Makino, Keita Yamasaki, Junya Azuma, Yoshiki Sawa, Hikaru Matsuda, Yasufumi Kaneda, and Toshio Ogihara
Hypertension published July 6, 2004, doi:10.1161/01.HYP.0000136394.08900.ed
[Abstract]
- Scientific Contributions
Heme Oxygenase-1 Gene Expression Modulates Angiotensin IIInduced Increase in Blood Pressure
- Liming Yang, Shuo Quan, Alberto Nasjletti, Michal Laniado-Schwartzman, and Nader G. Abraham
Hypertension 2004;43:1221-1226, doi:10.1161/01.HYP.0000126287.62060.e6
[Abstract]
[Full text]
- Scientific Contributions
Prevention of Cardiac Hypertrophy by Angiotensin II Type-2 Receptor Gene Transfer
- Beverly L. Metcalfe, Matthew J. Huentelman, Leonard D. Parilak, David G. Taylor, Michael J. Katovich, Harm J. Knot, Colin Sumners, and Mohan K. Raizada
Hypertension 2004;43:1233-1238, doi:10.1161/01.HYP.0000127563.14064.FD
[Abstract]
[Full text]
|
|